Yellow Card Scheme review: patient reporting recommended

被引:0
|
作者
机构
关键词
Public Health; Regulatory Agency; Product Regulatory; Interested Organisation; Reporting Rate;
D O I
10.2165/00128415-200410010-00007
中图分类号
学科分类号
摘要
引用
收藏
页码:3 / 3
相关论文
共 50 条
  • [2] The Views of Reporters to the UK Yellow Card Scheme on the Importance of Direct Patient Reporting
    Krska, Janet
    Taylor, Julia
    Avery, Anthony J.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S180 - S181
  • [3] The yellow card scheme: Evaluation of patient reporting of suspected adverse drug reactions
    Ekins-Daukes, S.
    Irvine, D.
    Wise, L.
    Fiddes, S.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S105 - S105
  • [4] The Yellow Card Scheme: Patient Reporting of Adverse Drug Reactions and Signals they have Generated
    Foy, M.
    Gandhi, S.
    Suri, S.
    Cumber, S.
    Jadeja, M. M.
    [J]. DRUG SAFETY, 2011, 34 (10) : 903 - 903
  • [5] A BRIEF REVIEW OF THE YELLOW CARD ADVERSE REACTION REPORTING SCHEME IN THE UNITED-KINGDOM
    BURTON, GH
    MANN, RD
    [J]. PHARMACOEPIDEMIOLOGY, VOL 1, 1989, : 121 - 132
  • [6] The Yellow Card Scheme: Experience of Patient Reporting of Adverse Drug Reaction Since Nationwide Launch
    Barrow, P. L.
    Foy, M.
    Gandhi, S.
    O'Keefe, V.
    King, C.
    Webb, R.
    [J]. DRUG SAFETY, 2009, 32 (10) : 968 - 968
  • [8] UK's MHRA Encourages Yellow Card Scheme Reporting
    不详
    [J]. PHARMACEUTICAL MEDICINE, 2018, 32 (04) : 305 - 305
  • [9] YELLOW CARD REPORTING
    KELLEHER, HC
    CARMICHAEL, AE
    [J]. BRITISH JOURNAL OF GENERAL PRACTICE, 1993, 43 (366): : 35 - 35
  • [10] The Yellow Card Scheme: Experience of Patient Reporting of Adverse Drug Reactions 5 Years Since Launch
    Cumber, Sarah L.
    Heffer, Sarah J.
    Gandhi, Shelley
    Avery, Anthony J.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S321 - S321